Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Zara Sheikh, Hui Xin Ong, Michele Pozzoli, Paul M Young & Daniela Traini. (2018) Is there a role for inhaled anti-inflammatory drugs in cystic fibrosis treatment?. Expert Opinion on Orphan Drugs 6:1, pages 69-84.
Read now
Read now
Articles from other publishers (32)
Chenghai Bai, Chen Wang & Yuan Lu. (2023) Novel Vectors and Administrations for mRNA Delivery. Small 19:46.
Crossref
Crossref
Piyush Pradeep Mehta & Vividha Dhapte-Pawar. 2023. Pulmonary Drug Delivery Systems: Material and Technological Advances. Pulmonary Drug Delivery Systems: Material and Technological Advances
213
245
.
Guangle Li, Dong Liu & Yi Y. Zuo. 2023. Nanomedicine. Nanomedicine
469
499
.
Popat Kumbhar, Arehalli Manjappa, Rohit Shah, Niraj Kumar Jha, Sachin Kumar Singh, Kamal Dua, John Disouza & Vandana Patravale. (2022) Inhalation delivery of repurposed drugs for lung cancer: Approaches, benefits and challenges. Journal of Controlled Release 341, pages 1-15.
Crossref
Crossref
Guangle Li, Dong Liu & Yi Y. Zuo. 2020. Nanomedicine. Nanomedicine
1
31
.
Moez Ghumman, Dinesh Dhamecha, Andrea Gonsalves, Lauren Fortier, Parand Sorkhdini, Yang Zhou & Jyothi U. Menon. (2021) Emerging drug delivery strategies for idiopathic pulmonary fibrosis treatment. European Journal of Pharmaceutics and Biopharmaceutics 164, pages 1-12.
Crossref
Crossref
Valentina Sala, Sophie Julie Cnudde, Alessandra Murabito, Alberto Massarotti, Emilio Hirsch & Alessandra Ghigo. (2021) Therapeutic peptides for the treatment of cystic fibrosis: Challenges and perspectives. European Journal of Medicinal Chemistry 213, pages 113191.
Crossref
Crossref
Joydeb Majumder & Tamara Minko. (2020) Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus. Advanced Therapeutics 4:2, pages 2000203.
Crossref
Crossref
Joydeb Majumder & Tamara Minko. (2021) Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19. The AAPS Journal 23:1.
Crossref
Crossref
Hitesh Malhotra, Anjoo Kamboj & Rupesh K. Gautam. 2021. Medicinal Plants for Lung Diseases. Medicinal Plants for Lung Diseases
583
608
.
Debabrata Ghosh Dastidar, Dipanjan Ghosh, Swarnasree Ghosh & Gopal Chakrabarti. 2021. Targeting Cellular Signalling Pathways in Lung Diseases. Targeting Cellular Signalling Pathways in Lung Diseases
847
902
.
Yi Ju, Christina Cortez‐Jugo, Jingqu Chen, Ting‐Yi Wang, Andrew J. Mitchell, Evelyn Tsantikos, Nadja Bertleff‐Zieschang, Yu‐Wei Lin, Jiaying Song, Yizhe Cheng, Srinivas Mettu, Md. Arifur Rahim, Shuaijun Pan, Gyeongwon Yun, Margaret L. Hibbs, Leslie Y. Yeo, Christoph E. Hagemeyer & Frank Caruso. (2020) Engineering of Nebulized Metal–Phenolic Capsules for Controlled Pulmonary Deposition. Advanced Science 7:6, pages 1902650.
Crossref
Crossref
Maria Julia Altube, Melina M. B. Martínez, Barbara Malheiros, Paulo C. Maffía, Leandro R. S. Barbosa, Maria Jose Morilla & Eder Lilia Romero. (2019) Fast Biofilm Penetration and Anti-PAO1 Activity of Nebulized Azithromycin in Nanoarchaeosomes. Molecular Pharmaceutics 17:1, pages 70-83.
Crossref
Crossref
Parijat Pandey, Meenu Mehta, Shakti Shukla, Ridhima Wadhwa, Gautam Singhvi, Dinesh Kumar Chellappan, Saurabh Satija, Gaurav Gupta, Rajendra Awasthi, Parteek Prasher, Philip M. Hansbro, Kamal Dua & Harish Dureja. 2020. Nanoformulations in Human Health. Nanoformulations in Human Health
449
468
.
Cecilia Velino, Francesca Carella, Alessio Adamiano, Maurizio Sanguinetti, Alberto Vitali, Daniele Catalucci, Francesca Bugli & Michele Iafisco. (2019) Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis. Frontiers in Bioengineering and Biotechnology 7.
Crossref
Crossref
Joydeb Majumder, Oleh Taratula & Tamara Minko. (2019) Nanocarrier-based systems for targeted and site specific therapeutic delivery. Advanced Drug Delivery Reviews 144, pages 57-77.
Crossref
Crossref
Caterina Cristallini, Niccoletta Barbani, Letizia Ventrelli, Chiara Summa, Sara Filippi, Tania Capelôa, Emanuela Vitale, Carlo Albera, Barbara Messore & Claudia Giachino. (2019) Biodegradable microparticles designed to efficiently reach and act on cystic fibrosis mucus barrier. Materials Science and Engineering: C 95, pages 19-28.
Crossref
Crossref
O.B. Garbuzenko, N. Kbah, A. Kuzmov, N. Pogrebnyak, V. Pozharov & T. Minko. (2019) Inhalation treatment of cystic fibrosis with lumacaftor and ivacaftor co-delivered by nanostructured lipid carriers. Journal of Controlled Release 296, pages 225-231.
Crossref
Crossref
Aiju TianChengzhi YangBaoling ZhuWenjing WangKai LiuYunqi JiangYuhui QiaoHaian FuZijian Li. (2018) Polyethylene-glycol-coated gold nanoparticles improve cardiac function after myocardial infarction in mice. Canadian Journal of Physiology and Pharmacology 96:12, pages 1318-1327.
Crossref
Crossref
Azza A. Mahmoud, Nermeen A. Elkasabgy & Abdelfattah A. Abdelkhalek. (2018) Design and characterization of emulsified spray dried alginate microparticles as a carrier for the dually acting drug roflumilast. European Journal of Pharmaceutical Sciences 122, pages 64-76.
Crossref
Crossref
Ling Ding, Chenfei Zhu, Fei Yu, Pengkai Wu, Gang Chen, Aftab Ullah, Kaikai Wang, Minjie Sun, Jing Li & David Oupický. (2018) Pulmonary delivery of polyplexes for combined PAI-1 gene silencing and CXCR4 inhibition to treat lung fibrosis. Nanomedicine: Nanotechnology, Biology and Medicine 14:6, pages 1765-1776.
Crossref
Crossref
Wing-Hin Lee, Ching-Yee Loo, Maliheh Ghadiri, Chean-Ring Leong, Paul M. Young & Daniela Traini. (2018) The potential to treat lung cancer via inhalation of repurposed drugs. Advanced Drug Delivery Reviews 133, pages 107-130.
Crossref
Crossref
Selvaraj Nataraja, Venkataraman Sriraman & Stephen Palmer. (2018) Allosteric Regulation of the Follicle-Stimulating Hormone Receptor. Endocrinology 159:7, pages 2704-2716.
Crossref
Crossref
Aysu Yurdasiper, Mesut Arıcı & Mine Ozyazici. 2018. Emerging Nanotechnologies in Immunology. Emerging Nanotechnologies in Immunology
165
201
.
Ji Yhee, Jintaek Im & Richard Nho. (2016) Advanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug Delivery. Journal of Clinical Medicine 5:9, pages 82.
Crossref
Crossref
Alexey Popov, Lisa Schopf, James Bourassa & Hongming Chen. (2016) Enhanced pulmonary delivery of fluticasone propionate in rodents by mucus-penetrating nanoparticles. International Journal of Pharmaceutics 502:1-2, pages 188-197.
Crossref
Crossref
María Moreno-Sastre, Marta Pastor, Amaia Esquisabel, Eulàlia Sans, Miguel Viñas, Aarne Fleischer, Esther Palomino, Daniel Bachiller & José Luis Pedraz. (2016) Pulmonary delivery of tobramycin-loaded nanostructured lipid carriers for Pseudomonas aeruginosa infections associated with cystic fibrosis. International Journal of Pharmaceutics 498:1-2, pages 263-273.
Crossref
Crossref
Andriy Kuzmov & Tamara Minko. (2015) Nanotechnology approaches for inhalation treatment of lung diseases. Journal of Controlled Release 219, pages 500-518.
Crossref
Crossref
Marcela A. Moretton, Maximiliano Cagel, Ezequiel Bernabeu, Lorena Gonzalez & Diego A. Chiappetta. (2015) Nanopolymersomes as potential carriers for rifampicin pulmonary delivery. Colloids and Surfaces B: Biointerfaces 136, pages 1017-1025.
Crossref
Crossref
Bruce K. Rubin & Ronald W. Williams. (2014) Emerging aerosol drug delivery strategies: From bench to clinic. Advanced Drug Delivery Reviews 75, pages 141-148.
Crossref
Crossref
Ivana d'Angelo, Claudia Conte, Maria Immacolata La Rotonda, Agnese Miro, Fabiana Quaglia & Francesca Ungaro. (2014) Improving the efficacy of inhaled drugs in cystic fibrosis: Challenges and emerging drug delivery strategies. Advanced Drug Delivery Reviews 75, pages 92-111.
Crossref
Crossref
Tamara Minko, Lorna Rodriguez-Rodriguez & Vitaly Pozharov. (2013) Nanotechnology approaches for personalized treatment of multidrug resistant cancers. Advanced Drug Delivery Reviews 65:13-14, pages 1880-1895.
Crossref
Crossref